APA (7th ed.) Citation

Tianyu Zhang, Nuannuan Li, Ru Wang, Yiying Sun, Xiaoyan He, Xiaoyan Lu, . . . Kaoxiang Sun. (2023). Enhanced therapeutic efficacy of doxorubicin against multidrug-resistant breast cancer with reduced cardiotoxicity. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Tianyu Zhang, Nuannuan Li, Ru Wang, Yiying Sun, Xiaoyan He, Xiaoyan Lu, Liuxiang Chu, and Kaoxiang Sun. Enhanced Therapeutic Efficacy of Doxorubicin Against Multidrug-resistant Breast Cancer with Reduced Cardiotoxicity. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Tianyu Zhang, et al. Enhanced Therapeutic Efficacy of Doxorubicin Against Multidrug-resistant Breast Cancer with Reduced Cardiotoxicity. Taylor & Francis Group, 2023.